RSDH appoints Hong as group CEO

He has been acting as group CEO since September 2021.

Ramsay Sime Darby Health Care (RSDH) has appointed Peter Hong as its Group CEO from 1 January this year.

With 28 years of experience in the healthcare industry in Southeast Asia, Hong has worked for several large multinational companies in the pharmaceutical and medical sectors. He has also overseen RSDH and joint venture partner Ramsay Health Care's progress during the pandemic to drive business growth and operational excellence.

"Peter is a seasoned executive with a multicultural and multinational background," RSDH chair Martyn Roberts said. "He is well-acquainted with our operations and has demonstrated his ability to balance strategic operational decision-making and financial discipline. Peter's hands-on leadership approach is strongly aligned with the group's philosophy of 'people caring for people.' We look forward to strengthening our market position under his leadership."

Hong stepped down from the RSDH Board on accepting the GCEO role, and the board will appoint a new director in the coming weeks.

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

The loss will not have any material impact on the company.
Around 66 hotels have submitted to offer their rooms for hotel isolation.
He has been acting as group CEO since September 2021.
Bidding for these projects may commence in the first half of 2022.
Cardholders can now seek treatment from units where they did not register.
The system will be implemented this year.
The new facility will provide care for Indonesians who get treatment overseas.
The system was the only one of its kind in the country.
Healthcare Asia will be back on 3 January 2022. 
The additional patents aim to address supply issues.
Evusheld is a long-acting antibody candidate for COVID-19 treatment.
Despite NCDs accounting for 41 million deaths annually, they are still healthcare's 'blind spot', expert says.
The gala was held in celebration of World AIDS Day 2021.
It won in the International Human-Machine Competition on Diabetes Management.
The new facility is the first of its kind in Singapore.